Citation: | Lan Chuan, Zhang Ming, Yan Lyunan, et al. Clinical experience analysis of liver transplantation from donation after citizen's death in 78 cases[J]. ORGAN TRANSPLANTATION, 2016, 7(4): 287-291. doi: 10.3969/j.issn.1674-7445.2016.04.008 |
[1] |
刘学民, 王博, 于良, 等.心脏死亡供体经典原位肝移植的单中心临床研究[J]. 器官移植, 2013, 4(1):23-27. http://www.organtranspl.com/browse/detail/qkid/62/id/337.html
Liu XM, Wang B, Yu L, et al. Single-center clinical study of orthotopic liver transplantation using donation after cardiac death[J]. Organ Transplant, 2013, 4(1):23-27. http://www.organtranspl.com/browse/detail/qkid/62/id/337.html
|
[2] |
Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors[J]. Liver Transpl,2010,16(8):943-949. doi: 10.1002/(ISSN)1527-6473
|
[3] |
中华医学会器官移植学分会. 中国心脏死亡器官捐献工作指南(第2版)[J/CD]. 中华移植杂志(电子版), 2012, 6(3):221-224.
Organ Transplantation Branch of Chinese Medical Association. Work guide of cardiac death organ donation in China (2nd edition)[J/CD]. Chin J Transplant(Electr Edit), 2012, 6(3):221-224.
|
[4] |
蓝柳根,秦科,董建辉,等. 公民逝世后器官捐献供肝移植31例临床效果分析[J].器官移植,2015,6(5):316-321. http://www.organtranspl.com/browse/detail/qkid/88/id/126.html
Lan LG, Qin K, Dong JH, et al. Clinical effect analysis of liver transplantation from donation after citizen's death in 31 cases[J]. Organ Transplant,2015,6(5):316-321. http://www.organtranspl.com/browse/detail/qkid/88/id/126.html
|
[5] |
Doyle MB, Collins K, Vachharajani N, et al. Outcomes using grafts from donors after cardiac death[J]. J Am Coll Surg,2015,221(1):142-152. doi: 10.1016/j.jamcollsurg.2015.03.053
|
[6] |
Savier E, Dondero F, Vibert E, et al. First experience of liver transplantation with type 2 donation after cardiac death in France[J]. Liver Transpl, 2015,21(5):631-643. doi: 10.1002/lt.24107
|
[7] |
Firl DJ, Hashimoto K, O'Rourke C, et al. Impact of donor age in liver transplantation from donation after circulatory death donors: a decade of experience at Cleveland Clinic[J]. Liver Transpl,2015,21(12):1494-1503. doi: 10.1002/lt.24316
|
[8] |
Detry O, Deroover A, Meurisse N, et al. Donor age as a risk factor in donation after circulatory death liver transplantation in a controlled withdrawal protocol programme[J]. Br J Surg,2014,101(7):784-792. doi: 10.1002/bjs.2014.101.issue-7
|
[9] |
Singhal AK, Sheng X, Drakos SG, et al. Impact of donor cause of death on transplant outcomes: UNOS registry analysis[J].Transplant Proc, 2009,41(9):3539-3544. doi: 10.1016/j.transproceed.2009.06.192
|
[10] |
Xia W, Ke Q, Wang Y, et al. Donation after cardiac death liver transplantation: graft quality evaluation based on pretransplant liver biopsy[J]. Liver Transpl,2015,21(6):838-846. doi: 10.1002/lt.v21.6
|
[11] |
赵强, 金倩雯, 邓雯,等. 中国二类DCD供肝移植后早期肝功能不全42例的危险因素分析[J].中华器官移植杂志, 2015, 36(5):276-279.
Zhao Q, Jin QW, Deng W, et al. Risk analysis of early allograft dysfuntion after liver transplantation from 42 cases of Chinese type II organ donation[J]. Chin J Organ Transplant, 2015, 36(5):276-279.
|
[12] |
Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool[J]. Transplantation,1997, 64(2):248-251. doi: 10.1097/00007890-199707270-00012
|
[13] |
Verran D, Kusyk T, Painter D, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation[J]. Liver Transpl, 2003,9(5):500-505. doi: 10.1053/jlts.2003.50099
|
[14] |
Frongillo F, Avolio AW, Nure E, et al. Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival[J]. Transplant Proc,2009,41(4):1268-1272. doi: 10.1016/j.transproceed.2009.03.096
|
[15] |
Gao F, Xu X, Ling Q, et al. Efficacy and safety of moderately steatotic donor liver in transplantation[J]. Hepatobiliary Pancreat Dis Int,2009,8(1):29-33. http://cn.bing.com/academic/profile?id=1601287648&encoded=0&v=paper_preview&mkt=zh-cn
|
[16] |
Spitzer AL, Lao OB, Dick AA, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment[J].Liver Transpl,2010,16(7):874-884. doi: 10.1002/lt.v16:7
|
[17] |
McCormack L, Dutkowski P, El-Badry AM, et al. Liver transplantation using fatty livers: always feasible?[J]. J Hepatol,2011,54(5):1055-1062. doi: 10.1016/j.jhep.2010.11.004
|
[18] |
Mateo R, Cho Y, Singh G, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data[J]. Am J Transplant,2006,6(4):791-796. doi: 10.1111/j.1600-6143.2006.01243.x
|
[19] |
Lee KW, Simpkins CE, Montgomery RA, et al. Factors affecting graft survival after liver transplantation from donation after cardiac death donors[J].Transplantation,2006,82(12):1683-1688. doi: 10.1097/01.tp.0000250936.73034.98
|
[20] |
Lee DD, Singh A, Burns JM, et al. Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in inferior survival[J]. Liver Transpl,2014,20(12):1447-1453. http://cn.bing.com/academic/profile?id=2002754214&encoded=0&v=paper_preview&mkt=zh-cn
|
[21] |
Fondevila C, Hessheimer AJ, Flores E, et al. Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation[J].Am J Transplant, 2012,12(1):162-170. doi: 10.1111/ajt.2012.12.issue-1
|